Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Published 25/03/2024, 09:34
Updated 25/03/2024, 10:40
© Reuters. Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday.

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.

The U.S. FDA approved broad new labels for Esperion's NEXLETOL® and NEXLIZET® to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use.

Esperion Therapeutics shares jumped 12.7% to $2.58 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

  • Forge Global Holdings, Inc. (NYSE: FRGE) shares gained 22.8% to $2.86 in pre-market trading after gaining 13% on Friday.
  • Canopy Growth Corporation (NASDAQ: CGC) gained 19.5% to $9.17 in pre-market trading. The German government approved legislation which legalizes the possession and cultivation of cannabis beginning April 1.
  • Masimo Corporation (NASDAQ: MASI) shares climbed 13.8% to $153.65 in pre-market trading after the company announced it has authorized management to evaluate a proposed separation of its consumer business. The company also reaffirmed its first-quarter and FY24 guidance.
  • Cronos Group Inc. (NASDAQ: CRON) rose 9.6% to $2.86 in pre-market trading after gaining 9% on Friday.
  • Nuvation Bio Inc. (NASDAQ: NUVB) gained 8.2% to $2.50 in pre-market trading after gaining 3% on Friday.
  • Tilray Brands, Inc. (NASDAQ: TLRY) gained 5.2% to $2.43 in pre-market trading after jumping 18% on Friday. Germany approved the legalization of cannabis for adult use.
  • WK Kellogg Co (NYSE: KLG) rose 4.8% to $19.49 in pre-market trading.
  • GoodRx Holdings, Inc. (NASDAQ: GDRX) shares climbed 4.1% to $6.85 in pre-market trading. Wells Fargo analyst Stan Berenshteyn upgraded GoodRx from Equal-Weight to Overweight and announced a $10 price target.
  • Century Aluminum Company (NASDAQ: CENX) shares gained 3.6% to $13.69 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Investor Optimism Improves Slightly; Dow Jumps Over 250 Points

Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.